Release Date: September 18, 2009 This content is archived.
An article in BusinessWeek about a letter sent by Sen. Chuck Grassley (R-Iowa) to the Food & Drug Administration questioning whether the agency has sufficiently considered potential problems caused by cholesterol-lowering drugs quotes Georgirene Vladutiu, professor of pediatrics, neurology and pathology and anatomical sciences, described patients who are wheelchair-bound from muscle weakness and pain five years after they have stopped taking statins.
John Della Contrada
Vice President for University Communications
521 Capen Hall
Buffalo, NY 14260
Tel: 716-645-4094 (mobile: 716-361-3006)
dellacon@buffalo.edu
Twitter: UBNewsSource